Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1100777.RAnXZurk0W9mT_JoPySm1RNp9tBu4sCaF53kYPfBN5pLI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1100777.RAnXZurk0W9mT_JoPySm1RNp9tBu4sCaF53kYPfBN5pLI130_assertion type Assertion NP1100777.RAnXZurk0W9mT_JoPySm1RNp9tBu4sCaF53kYPfBN5pLI130_head.
- NP1100777.RAnXZurk0W9mT_JoPySm1RNp9tBu4sCaF53kYPfBN5pLI130_assertion description "[In addition, GRP94 may represent a key biomarker for determining the therapeutic efficacy of taxane treatment in cervical cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1100777.RAnXZurk0W9mT_JoPySm1RNp9tBu4sCaF53kYPfBN5pLI130_provenance.
- NP1100777.RAnXZurk0W9mT_JoPySm1RNp9tBu4sCaF53kYPfBN5pLI130_assertion evidence source_evidence_literature NP1100777.RAnXZurk0W9mT_JoPySm1RNp9tBu4sCaF53kYPfBN5pLI130_provenance.
- NP1100777.RAnXZurk0W9mT_JoPySm1RNp9tBu4sCaF53kYPfBN5pLI130_assertion SIO_000772 23929391 NP1100777.RAnXZurk0W9mT_JoPySm1RNp9tBu4sCaF53kYPfBN5pLI130_provenance.
- NP1100777.RAnXZurk0W9mT_JoPySm1RNp9tBu4sCaF53kYPfBN5pLI130_assertion wasDerivedFrom befree-2016 NP1100777.RAnXZurk0W9mT_JoPySm1RNp9tBu4sCaF53kYPfBN5pLI130_provenance.
- NP1100777.RAnXZurk0W9mT_JoPySm1RNp9tBu4sCaF53kYPfBN5pLI130_assertion wasGeneratedBy ECO_0000203 NP1100777.RAnXZurk0W9mT_JoPySm1RNp9tBu4sCaF53kYPfBN5pLI130_provenance.